cooper development lt bug restate result cooper development co say revise result year end october 31 loss 61 7 mln dlrs 2 33 dlrs per share previously report loss 12 1 mln dlrs 46 ct per share restatement make change method account combination several company control concern result 53 5 mln dlr charge cooper development say last august cooper development combine cooper biomedical inc unit cooper laboratory subsidiary technicon instrument corp company acquire revlon inc lt rev >, cooper spokesman say spokesman say transaction account acquisition security exchange commission take issue account method say account reorganization entity common control treatment require cost associate transaction expand rather capitalize intangible asset company say also say since charge require expense previously accrue liability company experience result material change cash flow 